Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmacia Diagnostics, now known as Phadia and operating as the ImmunoDiagnostics Division of Thermo Fisher Scientific, is the global leader in allergy and autoimmune disease diagnostics. The company is renowned for developing the ImmunoCAP technology, which is considered the gold standard for blood-based allergy testing, enabling the precise identification of specific allergens. Their portfolio also includes the EliA system, which provides automated solutions for diagnosing a wide range of autoimmune conditions such as rheumatoid arthritis and celiac disease. Headquartered in Uppsala, Sweden, the company has a long history of innovation dating back to the first commercial IgE test in the 1970s. Today, their systems are used by clinical laboratories worldwide to improve the diagnosis and management of allergic and immunologic disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmacia Diagnostics.